North America’s BEST Small Cap Stock Ideas
On Monday, our favorite biotech stock Hemispherx Biopharma (HEB), announced that it had agreed to sell up to $18.3 million in common stock and warrants in a registered offering to two institutional investors. In return for $15 million cash, the new investors received common shares of HEB’s stock at $1.10 per share. Additionally, they will receive Series A warrants to […]
Read moreYou may wonder what Acme United (ACU – $8.00), a ruler and scissors company, has to do with swine flu? Well, Acme United has a division called PhysiciansCare, which offers a wide assortment of first aid kits, over-the-counter medicines, emergency and disaster kits, preparedness products and kit refills. One particular product being sold by PhysiciansCare, are N95 respirators, which are […]
Read moreOur original interest with Hemispherx Biopharma (HEB) was the fact that one of its experimental products was under active review with the United States Food and Drug Administration for the treatment of Chronic Fatigue Syndrome. However, our interest in today’s interview is to discuss the recent events of the spread of swine influenza that is all over the news in […]
Read moreThe World Health Organization (WHO) will hold an emergency meeting today (Saturday, April 25, 2009) to discuss a deadly swine flu strain outbreak in Mexico and the United States. The WHO’s director-general, Margaret Chan, said the outbreak of the never-before-seen virus is a very serious situation and has “pandemic potential.” But she said it is still too early to tell […]
Read moreOn Wednesday, Orsus Xelent Technologies, Inc. (ORS), a designer and manufacturer of mobile phones for the Asian market, announced its full year 2008 results. Revenues for the full year ended December 31, 2008 grew approximately 20% to $107,827,000, compared with $89,923,000 in 2007. Full year net income grew 16.6% to $11,296,000 or $.38 per share, compared with $9,683,000 or $0.33 […]
Read moreOn Friday, Acme United Corporation (ACU – $7.20) announced sales and earnings for the first quarter ended March 31, 2009. As expected, those numbers were soft due to a reduction in orders from many of the Company’s customers as a result of the contracting global economy. However, the Company did manage to remain profitable thanks to a series of cost […]
Read more
In this interview Mr. Walter Johnsen, Exec. Chairman and CEO of Acme United Corp. (ACU – $7.20), gives us an update on the Company’s current condition. He talks about the Company’s dividend policy, the share buyback program and its European segment. Additionally, he gives us some insights on first quarter results. This is an interview worthwhile your time. Click the […]
Read moreDoes the board of Orsus Xelent Technologies Inc. (ORS) read my posts? In my post last week, I wrote that Orsus, a designer and manufacturer of award-winning mobile phones for the Asian market, was my only disappointment so far this year. And what do you know? On Thursday the Company announced a big management shift. Mr. Xin Wang, CEO and […]
Read moreOn Wednesday, James Reindl, Chairman, Director and CEO of TechPrecision Corp. (TPCS) resigned. The press release stated: “Mr. Reindl submitted his resignation and confirmed that despite briefly attending the University of Delaware, he did not receive a degree from the University of Delaware as he had previously represented.” When I visited the TPCS website, Mr. Reindl’s profile was already gone. […]
Read moreLast week, Dr. Strayer, Hemispherx Biopharma’s (NYSE Alternext US: HEB) Medical Director, presented new cytokine and cardiovascular data at the 9th International IACFS/ME conference. This week, Dr. Strayer and Dr Carter, Hemispherx’ CEO, held a conference call in which they gave an update on the Company’s FDA progress and the new released data. In my previous Hemispherx update, which was […]
Read more